Source: http://www.google.com/patents/US8034016?dq=7,403,220
Timestamp: 2017-10-20 11:12:34
Document Index: 665367143

Matched Legal Cases: ['art.\n3', 'arts 71', 'arts 71', 'arts 71', 'arts 71', 'arts 81', 'arts 81', 'arts 81', 'arts 81']

Patent US8034016 - Flow regulating implants and methods of implanting - Google Patents
A flow regulating implant is provided with one or more grooves for allowing fluid flow. One or more grooves may have a constant or varying cross-section along its length. One or more grooves may have in it biodegradable material, absorbable material, and/or threads or sutures. A resilient band or coating...http://www.google.com/patents/US8034016?utm_source=gb-gplus-sharePatent US8034016 - Flow regulating implants and methods of implanting
Publication number US8034016 B2
Application number US 11/952,754
Also published as CA2571871A1, CA2571871C, CN100577127C, CN101076305A, CN101732125A, CN101732125B, EP1765234A2, US7862531, US20050288617, US20080077071, WO2006012009A2, WO2006012009A3
Publication number 11952754, 952754, US 8034016 B2, US 8034016B2, US-B2-8034016, US8034016 B2, US8034016B2
Inventors Ira Yaron, Elie Dahan
Original Assignee Optonol, Ltd.
Patent Citations (171), Non-Patent Citations (5), Referenced by (3), Classifications (20), Legal Events (2)
Flow regulating implants and methods of implanting
US 8034016 B2
A flow regulating implant is provided with one or more grooves for allowing fluid flow. One or more grooves may have a constant or varying cross-section along its length. One or more grooves may have in it biodegradable material, absorbable material, and/or threads or sutures. A resilient band or coating may be placed around the implant or one or more grooves, to act as a pressure regulator. The implant may have a side projection, such as a side pin, for engaging tissue. The implant may comprise two or more parts that are held at a distance from each other to allow fluid flow between the parts.
1. A method of implanting an intraocular implant at an implantation site comprising the steps of:
(a) using an intraocular implant having an inlet end and an outlet end, the intraocular implant comprising:
(i) an elongated portion comprising a first elongated part and a second elongated part, wherein the first elongated part is separated from the second elongated part to leave a space between the first elongated part and the second elongated part for enabling fluid flow; and
(ii) a flange attached to at least the first elongated part, the flange being located at the outlet end of the intraocular implant;
(b) adjusting the spacing between the first elongated part and the second elongated part; and
(c) inserting the intraocular implant through scleral tissue at the implantation site such that the inlet end of the intraocular implant is located within the anterior chamber of the eye, thereby permitting aqueous humor to flow out of the anterior chamber.
2. The method of claim 1, wherein the flange projects from the first elongated part at an angle with respect to the first elongated part.
3. The method of claim 1, wherein the first elongated part and the second elongated part are formed together as parts of a single, one-piece implant.
4. A method of implanting an intraocular implant at an implantation site comprising the steps of:
(i) a shaft, wherein the shaft has one or more grooves in the side of the shaft for enabling fluid flow; and
(ii) a flange located at the outlet end of the intraocular implant;
(b) adjusting the spacing between a first elongated part and a second elongated part of the intraocular implant; and
(c) inserting the intraocular implant through scleral tissue at the implantation site such that the inlet end of the intraocular implant is located within the anterior chamber of the eye, and such that aqueous humor flows out of the anterior chamber and along the one or more grooves toward the outlet end of the implant.
5. The method of claim 4, wherein the cross section of at least one groove is constant along its length.
6. The method of claim 4, wherein at least one groove is tapered.
7. The method of claim 4, further comprising removable material located in at least one groove.
8. The method of claim 7, wherein the removable material is a laser-ablatable materials.
9. The method of claim 7, wherein the removable material is a removable thread or suture.
10. The method of claim 4, further comprising a degradable material located in at least one groove.
11. The method of claim 4, further comprising an absorbable material located in at least one groove.
12. The method of claim 4, further comprising a resilient band or coating covering at least a portion of at least one groove.
13. The method of claim 4, further comprising a projection extending from the side of the shaft for anchoring the implant within tissue.
14. The method of claim 4, wherein the cross-section of the shaft is non-circular.
15. A method of implanting an intraocular implant at an implantation site comprising the steps of:
(i) a shaft, wherein the shaft has one or more grooves located on the external surface of the shaft and extending from the inlet end to the outlet end for enabling fluid flow; and
This application is a division of application Ser. No. 10/875,571 filed Jun. 25, 2004 now U.S. Pat. No. 7,862,531.
The invention relates generally to flow regulating implants, for example ophthalmic implants for treatment of glaucoma.
U.S. Pat. No. 5,868,697 discloses devices and methods for regulating fluid flow. The devices and methods are useful, for example, in the treatment of glaucoma, by providing for the flow of aqueous humor from the eye to reduce intraocular pressure (IOP). The devices and methods disclosed in that patent are expressly incorporated by reference into this specification.
As with the devices and methods disclosed in U.S. Pat. No. 5,868,697, the devices and methods disclosed herein are also for regulating fluid flow. The devices and methods disclosed herein are useful, for example, in the treatment of glaucoma, by providing for the flow of aqueous humor from the eye to reduce intraocular pressure (IOP).
In certain embodiments, the invention is directed to an improved flow regulating implant that has one or more grooves for allowing fluid flow.
In certain embodiments, one or more grooves may have a constant cross-section along its length.
In certain embodiments, one or more grooves may have a varying cross-section along its length. For example, one or more grooves may be tapered, as a funnel. The wider end may be at the inlet end or the outlet end.
In certain embodiments, one or more grooves may have in it biodegradable material, absorbable material, and/or threads or sutures.
In certain embodiments, a resilient band or coating may be placed around the implant or one or more grooves, to act as a pressure regulator.
In certain embodiments, in addition to one or more grooves, the implant may have a tube passage running through it. The tube passage may have in it biodegradable material, absorbable material, and/or threads or sutures.
In certain embodiments, the implant may have a side projection, such as a side pin, for engaging tissue. The side projection or pin may be useful for resisting rotation and/or firmly holding the implant within the tissue.
In certain embodiments, the implant may comprise two or more parts that are held at a distance from each other to allow fluid flow between the parts.
FIG. 1 is a perspective view of a first embodiment of a flow regulating implant;
FIG. 2 is an alternative perspective view of the flow regulating implant of FIG. 1;
FIG. 3 is an alternative perspective view of the flow regulating implant of FIG. 1;
FIG. 4 is a perspective view of the flow regulating implant of FIG. 1, with material in the side grooves;
FIG. 5 is a perspective view of the flow regulating implant of FIG. 1, with threads or sutures in the side grooves;
FIG. 6 is a perspective view of the flow regulating implant of FIG. 1, with a flow regulating band or coating around the implant;
FIG. 7 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with holes at the outlet ends of the grooves;
FIG. 8 is a perspective view of another alternative embodiment of a flow regulating implant with side grooves, with a hole in the flange at the outlet end of the implant;
FIG. 9 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with an alternative flange design at the outlet end of the implant;
FIG. 10 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves, with a tube passage running through the implant;
FIG. 11 is a perspective view of the flow regulating implant of FIG. 10, with a thread or suture in the tube passage;
FIG. 12 is a perspective view of an alternative embodiment of a flow regulating implant, with a side pin;
FIG. 13 is a perspective view of an alternative embodiment of a flow regulating implant, comprising two parts that are held at a distance from each other to allow fluid flow between the parts;
FIG. 14 is a perspective view of an alternative embodiment of a flow regulating implant, comprising two parts that are held at a distance from each other to allow fluid flow between the parts, wherein the two parts may be pushed together or moved apart.
FIGS. 1 to 3 illustrate a first embodiment of a flow regulating implant. The illustrated implant is in the form of an intraocular implant 10. The implant 10 comprises a shaft 11 and a flange (or plate or disk) 12. The cross-section of the shaft may take any suitable shape, for example square, rectangular, ellipsoidal, circular, or an irregular shape. In this illustrated embodiment, the plane of the flange 12 forms an angle with the shaft 11 that corresponds generally to the angle between the surface of the sclera of an eye and the intended axis of insertion of the implant 10. The flange 12 limits the depth of insertion and stabilizes the device. The angling of the flange 12 helps limit or prevent rotation of the device. In certain applications, it may be desired to remove the device, in which case the flange may be used for that purpose.
The implant 10 has an inlet end 13 and an outlet end 14. The flange 12 is connected to the shaft 11 at the outlet end 14 of the implant 10. The implant 10 may have one or more retention projections 15 for retaining the implant 10 after insertion. The retention projection(s) 15 may take any suitable form.
In the illustrated embodiment, the shaft 11 has a rounded tip at the inlet end 13 of the implant 10. It will be appreciated that the tip may take other suitable forms. For example, the tip may be a needle-like tip formed by a beveled surface, angled sharply for easy insertion into the eyeball.
The implant 10 has two side grooves 16A, 16B. In the illustrated embodiment, the side grooves 16A, 16B extend the full length of the implant 10, from the inlet end 13 to the outlet end 14. The side grooves 16A, 16B are in the side of the shaft 11 and extend through the flange 12.
An implant in accordance with the invention may be inserted by methods disclosed in U.S. Pat. No. 5,868,697, incorporated herein by reference. The insertion of the implant is not restricted to those methods. In certain instances, it may be desirable to implant the device such that the flange is located under scleral flap, i.e., a flap of tissue cut from the sclera. In such a method, a scleral flap is carefully cut from the sclera. The cut is preferably not made all the way through the sclera to the anterior chamber. Rather, the cut extends only part way through, to create the scleral flap that can be moved away to expose a place for insertion of the implant. With the scleral flap lifted, the implant is inserted in the intended implantation site, with the flange under the scleral flap. The implantation of the device under a scleral flap may assist in absorption of fluid. It also may assist in retention of the device.
With the device as illustrated in FIGS. 1 to 3, in operation, the grooves 16A, 16B form passageways for fluid to flow from the inlet end 13 toward the outlet end 14 of the implant 10. In the case of an intraocular implant, the aqueous humor in the eye can flow along the grooves from the inlet end 13 toward the outlet end 14.
The grooves 16A, 16B are directly adjacent the tissue into which the implant 10 is implanted. Thus, for example, the scleral tissue of the eye will surround the implant. In this manner, the scleral tissue can function as a valve to control the flow of fluid out of the eye. When the pressure in the anterior chamber is low, the tissue is close around the implant and in the grooves to block or limit the flow of fluid along the grooves. When the pressure in the anterior chamber is elevated, the fluid exerts pressure on the tissue to clear the passageway along the grooves, and fluid will flow along the grooves between the implant device and the tissue.
With the grooves, the aqueous humor flowing out of the anterior chamber is allowed to directly contact the scleral tissue, which allows for direct absorption of the aqueous humor by the sclera. The fluid may be absorbed by the sclera or may flow out, for example underneath the conjunctiva.
The groove(s) may take any suitable form. For example, one or more grooves may be shaped as a funnel, tapering from one end to the other. The wider end may be at the outlet end or the inlet end, depending on the desired application. Other modifications to the size, shape, and/or cross-sectional configuration of the groove(s) may be made.
It will be appreciated that in addition to the flow regulation characteristics, the grooves may serve the additional benefit of limiting or preventing rotation of the device. It will also be appreciated that non-circular cross-sections for the shaft will also help limit or prevent rotation of the device. For example, a cross-section having corners, like a square, rectangular or other polygonal cross-section, will help limit or prevent rotation. In addition, a cross-section with different dimensions in different direction, like an elliptical or rectangular cross-section, will help limit or prevent rotation. The grooves may help to limit or prevent rotation even with an otherwise circular cross-section for the shaft. The tissue in the gutters may help hold the position of the device.
FIG. 4 illustrates the flow regulating implant of FIG. 1, with material 17 in the side grooves. In this example, the material 17 may be a biodegradable material, an absorbable material, or a material that may be ablated with a laser. Such materials may act to block or limit flow initially and to allow more flow over time. For example, a physician may ablate the laser-ablatable material at some period of time after implantation, or in increments over time. The biodegradable or absorbable material may act to block flow upon initial implantation and to erode or degrade over time to allow more flow. Further descriptions of the use of such materials in flow regulating implants are provided in U.S. Pat. Nos. 6,203,513 and 6,558,342, the disclosures of which are incorporated herein by reference.
FIG. 5 illustrates the flow regulating implant of FIG. 1, with threads or sutures 18 in the side grooves. The threads or sutures 18 may act to block or limit flow initially and to allow more flow over time. For example, a physician may remove the threads or sutures 18 at some period of time after implantation, or may remove one at a time in increments over time. It will be appreciated that more than one thread or suture 18 may be placed in each groove. Further descriptions of the use of threads or sutures in flow regulating implants are provided in U.S. Pat. No. 6,558,342, the disclosure of which is incorporated herein by reference.
FIG. 6 illustrates the flow regulating implant of FIG. 1, with a flow regulating band or coating 19 around the implant. The band or coating 19 may extend over only part of the length of the implant, as illustrated, or, alternatively, it may extend over the full length of the implant. The band or coating 19 may be shaped to extend into the grooves. The band or coating 19 is resilient and acts as valve to control the flow of fluid out of the eye. When the pressure in the anterior chamber is low, the band or coating 19 is close around the implant and in the grooves to block or limit the flow of fluid along the grooves. When the pressure in the anterior chamber is elevated, the fluid exerts pressure on the band or coating 19 to clear the passageway along the grooves, and fluid will flow along the grooves between the implant shaft and the band or coating 19.
FIG. 7 illustrates another embodiment of a flow regulating implant. This flow regulating implant 20 is similar to the flow regulating implant 10. The flow regulating implant 20 has a shaft 21, a flange 22, and grooves 26A, 26B (groove 26B not shown). In this embodiment, the flange has holes 27A, 27B in it at the outlet ends of the grooves 26A, 26B, respectively. These holes allow the flow of fluid away from the implant.
FIG. 8 illustrates another embodiment of a flow regulating implant. This flow regulating implant 30 is similar to the flow regulating implants described above. The flow regulating implant 30 has a shaft 31, a flange 32, and grooves 36A, 36B. In this embodiment, the flange has a hole 38 in it. With this hole, a suture may be used to attach the implant to tissue to fix it in place.
FIG. 9 illustrates a flow regulating implant 40. This flow regulating implant 40 is similar to the flow regulating implants described above. The flow regulating implant 40 has a shaft 41, a flange 42, and grooves 46A, 46B. In this embodiment, the flange 42 has a different shape, which may be useful in certain applications.
FIG. 10 is a perspective view of an alternative embodiment of a flow regulating implant with side grooves. The implant 50 has tube passage 51 running through the implant. This tube passage 51 provides an additional passageway for fluid flow. The tube passage may have in it absorbable, biodegradable, laser-ablatable and/or removable material for blocking or partially obstructing fluid flow, and for allowing further flow over time. FIG. 11 illustrates the flow regulating implant of FIG. 10, with a thread or suture 58 in the tube passage 51.
FIG. 12 is a perspective view of an alternative embodiment of a flow regulating implant 60, with a side projection in the form of a side pin 68. Upon implantation, the pin 68 is fixed in the scleral tissue and serves to resist rotation of the device. The pin 68 may also assist in holding the device in the sclera, providing a sealing of the sclera around the shaft of the implant to prevent undesired leakage. The pin also fixes the device to prevent the possibility of the device pressing on and eroding the conjunctiva.
The projection or pin could be may of any suitable material, and it could be removable or changeable. For example, the projection or pin could be made of absorbable, biodegradable, laser-ablatable and/or removable material. The projection or pin 68 could be movable with a hole in the shaft 61, so that its length of projection from the shaft 61 could be adjustable. Also, a slot or other holes could be provided to allow adjustment of the positioning of the projection or pin.
FIG. 13 is a perspective view of an alternative embodiment of a flow regulating implant. The implant 70 comprises two parts 71, 72 that are held at a distance from each other to allow fluid flow between the parts. In implant 70, the two parts 71, 72 are joined to each other by two cylinders 73A, 73B. The implant may be formed as one piece, or the parts may be joined by any suitable means, for example welding. The two parts 71, 72 may be joined by just one cylinder or by parts of other shapes, for example, one or more spheres. Alternatively, the two parts may be shaped to be joined directly together with a space between them. It will be appreciated that the space 74 between the parts 71, 72 provides a space for the flow of fluid and allows further fluid contact with the sclera.
FIG. 14 illustrates a flow regulating implant 80 comprising an elongated portion having two elongated parts 81, 82 that are formed together as parts of a single, one-piece device. As illustrated in FIG. 14 and similar to previous embodiments discussed above, a flange 85 is attached to and projects at an angle with respect to each of the two elongated parts 81, 82. It will be appreciated that the space 84 between the parts 81, 82 provides a space for the flow of fluid and allows further fluid contact with the sclera, similar to the implant 70. The two parts 81, 82 may be pushed together or moved apart, which can control the spacing and thus the fluid flow.
An implant constructed in accordance with the invention may be manufactured entirely from or covered with any suitable material, such as stainless steel, silicon, gold, nitinol, Teflon, tantalum, PMMA, or any other suitable metallic or polymeric or other material. The entire device may be made from a degradable material. The device may be made by molding or any other suitable method of manufacture. The device may be manufactured as one piece or as separate pieces that are joined together. The implant may be coated with heparin or any other suitable coating.
Implants in accordance with the invention may be provided with other features and/or implanted with delivery devices and/or by other methods, for example those disclosed in U.S. Pat. Nos. 5,868,697; 6,203,513 and 6,558,342, discussed above.
As will be appreciated by persons having ordinary skill in the art, the various embodiments of implants described hereinabove are given by way of example only. Various changes, modifications and variations may be applied to the described embodiments without departing from the scope of the invention, defined by the appended claims.
US1388172 Mar 18, 1920 Aug 23, 1921 Craddock Simon M Veterinary surgical appliance
US2555076 Nov 17, 1947 May 29, 1951 Crossley Elijah R Instrument for use in performing surgical eye operations
US3310051 Dec 10, 1963 Mar 21, 1967 Schulte Rudolf R Surgical reservoir for implantation beneath the skin
US3333588 Jul 6, 1964 Aug 1, 1967 Schulte Rudolf R Brain ventricle cannula
US3530860 Jan 9, 1967 Sep 29, 1970 Majoros Marton Method and apparatus for inserting a tube through the ear drum
US3589401 Jul 18, 1969 Jun 29, 1971 Case Co J I Pressure modulating valve
US3890976 Jan 21, 1974 Jun 24, 1975 Medical Products Corp Catheter tip assembly
US3915172 Mar 26, 1973 Oct 28, 1975 Ceskoslovenska Akademie Ved Capillary drain for glaucoma
US3957035 Jan 17, 1975 May 18, 1976 Jean Chassaing Ophthalmological device useful for eye surgery
US4142526 Mar 9, 1977 Mar 6, 1979 Alza Corporation Osmotic releasing system with means for changing release therefrom
US4290426 Dec 31, 1979 Sep 22, 1981 Alza Corporation Dispenser for dispensing beneficial agent
US4299227 Oct 19, 1979 Nov 10, 1981 Lincoff Harvey A Ophthalmological appliance
US4303063 Mar 6, 1980 Dec 1, 1981 Stahl Norman O Ocular massage device
US4474569 Jun 28, 1982 Oct 2, 1984 Denver Surgical Developments, Inc. Antenatal shunt
US4521210 * Dec 27, 1982 Jun 4, 1985 Wong Vernon G Eye implant for relieving glaucoma, and device and method for use therewith
US4526343 Oct 26, 1984 Jul 2, 1985 Society Nationale D'etude Et De Construction De Moteurs D'aviation, "S.N.E.C.M.A." Device for the distribution of a fluid
US4538611 Jun 13, 1983 Sep 3, 1985 Kelman Charles D Surgical instrument and method of cutting a lens of an eye
US4578058 Apr 2, 1984 Mar 25, 1986 Grandon Stanley C Intraocular catheter apparatus and method of use
US4598705 Jan 13, 1984 Jul 8, 1986 Lichtenberger Gyoergy Trachea cannula
US4645493 Oct 21, 1985 Feb 24, 1987 N.U.S. S.R.L. Catheter for medical-surgical application
US4692142 Feb 24, 1986 Sep 8, 1987 Dignam Bernard J Sutureless infusion cannula for ophthalmic surgery
US4722724 Jun 23, 1986 Feb 2, 1988 Stanley Schocket Anterior chamber tube shunt to an encircling band, and related surgical procedure
US4750971 Jan 27, 1987 Jun 14, 1988 U.S. Philips Corporation Method of manufacturing a semiconductor device
US4781675 Aug 27, 1987 Nov 1, 1988 White Thomas C Infusion cannula
US4813941 Sep 3, 1987 Mar 21, 1989 Leslie Shea Pneumothorax treatment device
US4826478 Aug 21, 1987 May 2, 1989 Stanley Schocket Anterior chamber tube shunt to an encircling band, and related surgical procedure
US4909783 Oct 14, 1987 Mar 20, 1990 Morrison David P Intra-ocular pressure apparatus
US5000731 Mar 30, 1989 Mar 19, 1991 Tai-Ting Wong Shunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus
US5053040 Feb 11, 1991 Oct 1, 1991 Goldsmith Iii Manning M Method of performing a myringotomy
US5064417 Oct 11, 1989 Nov 12, 1991 Co Pharma Corporation S.R.L. Device for fastening a catheter to a cranial theca for performing cerebro spinal fluid drainage to the outside operations
US5071408 Feb 12, 1990 Dec 10, 1991 Ahmed Abdul Mateen Medical valve
US5098438 Aug 23, 1990 Mar 24, 1992 Siepser Steven B Procedures for intraocular surgery
US5106367 Nov 28, 1989 Apr 21, 1992 Alexander Ureche Eye surgery apparatus with vacuum surge suppressor
US5167620 Jan 22, 1992 Dec 1, 1992 Alexandar Ureche Eye surgery methods
US5207660 Apr 26, 1991 May 4, 1993 Cornell Research Foundation, Inc. Method for the delivery of compositions to the ocular tissues
US5221278 Mar 12, 1992 Jun 22, 1993 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5242449 Apr 16, 1992 Sep 7, 1993 Allergan, Inc. Ophthalmic instrument
US5318558 Dec 1, 1992 Jun 7, 1994 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5326345 Nov 3, 1992 Jul 5, 1994 Price Jr Francis W Eye filtration prostheses
US5342370 Mar 19, 1993 Aug 30, 1994 University Of Miami Method and apparatus for implanting an artifical meshwork in glaucoma surgery
US5355871 Sep 11, 1992 Oct 18, 1994 Dexide, Inc. Elastomeric controller for endoscopic surgical instruments
US5358492 Sep 30, 1992 Oct 25, 1994 Feibus Miriam H Woven surgical drain and method of making
US5360398 Nov 4, 1993 Nov 1, 1994 Grieshaber & Co. Ag Schaffhausen Ophthalmological aspiration and irrigation system
US5403323 May 13, 1993 Apr 4, 1995 Smith; Stewart G. Method and apparatus for phaco-emulsification
US5433701 * Dec 21, 1994 Jul 18, 1995 Rubinstein; Mark H. Apparatus for reducing ocular pressure
US5433714 Apr 27, 1993 Jul 18, 1995 Bloomberg; Leroy Topical anesthesia method for eye surgery, and applicator therefor
US5451229 Apr 22, 1994 Sep 19, 1995 Hans Geuder Gmbh Cannula for an eye-surgery instrument
US5558630 * Dec 30, 1994 Sep 24, 1996 Fisher; Bret L. Intrascleral implant and method for the regulation of intraocular pressure
US5616118 Jul 1, 1994 Apr 1, 1997 Ahmed; Abdul M. Uniquely shaped ophthalmological device
US5626558 * May 5, 1995 May 6, 1997 Suson; John Adjustable flow rate glaucoma shunt and method of using same
US5660205 Dec 15, 1994 Aug 26, 1997 Epstein; Alan B. One-way valve
US5674286 Jul 15, 1992 Oct 7, 1997 United States Surgical Corporation Bioabsorbable medical implants
US5709698 Feb 26, 1996 Jan 20, 1998 Linvatec Corporation Irrigating/aspirating shaver blade assembly
US5800376 Apr 7, 1997 Sep 1, 1998 Medtronic, Inc. Burr-hole flow control device
US5807240 Sep 24, 1996 Sep 15, 1998 Circon Corporation Continuous flow endoscope with enlarged outflow channel
US5879319 * Jun 20, 1995 Mar 9, 1999 Chauvin Opsia Sclerotomy implant
US6186974 Jan 12, 1998 Feb 13, 2001 University College London And Moorfields Eye Hospital Nhs Trust Device for use in the eye
US6203513 Nov 20, 1997 Mar 20, 2001 Optonol Ltd. Flow regulating implant, method of manufacture, and delivery device
US6221078 Jun 25, 1999 Apr 24, 2001 Stephen S. Bylsma Surgical implantation apparatus
US6245077 Jan 21, 2000 Jun 12, 2001 Exmoor Plastics Ltd. Universal myringotomy tube/aural grommet inserter and methods
US6280468 Apr 16, 1998 Aug 28, 2001 Ras Holding Corp Scleral prosthesis for treatment of presbyopia and other eye disorders
US6299640 Dec 27, 1999 Oct 9, 2001 R A S Holding Corp Scleral prosthesis for treatment of presbyopia and other eye disorders
US6450984 Apr 26, 2000 Sep 17, 2002 Gmp Vision Solutions, Inc. Shunt device and method for treating glaucoma
US6730056 * Sep 21, 2000 May 4, 2004 Motorola, Inc. Eye implant for treating glaucoma and method for manufacturing same
US7008396 * Aug 30, 2000 Mar 7, 2006 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US7041077 Jul 21, 2003 May 9, 2006 Yale University Uveoscleral drainage device
US7862531 * Jun 25, 2004 Jan 4, 2011 Optonol Ltd. Flow regulating implants
US20010000527 * Dec 4, 2000 Apr 26, 2001 Optonol Ltd. Flow regulating implant, method of manufacture, and delivery device
US20040015140 Jul 21, 2003 Jan 22, 2004 Shields Milton B. Uveoscleral drainage device
US20040147870 Oct 28, 2003 Jul 29, 2004 Burns Thomas W. Glaucoma treatment kit
US20050119601 Aug 16, 2002 Jun 2, 2005 Lynch Mary G. Shunt device and method for treating glaucoma
US20050266047 Mar 18, 2005 Dec 1, 2005 Hosheng Tu Injectable glaucoma implants with multiple openings
US20060069340 * Nov 3, 2005 Mar 30, 2006 Solx, Inc. Shunt for the treatment of glaucoma
USD356867 Mar 10, 1993 Mar 28, 1995 Hood Laboratories Device for controlling intraocular fluid pressure
USRE34998 Jun 15, 1993 Jul 18, 1995 Langerman David W "Spare parts" for use in ophthalmic surgical procedures
EP102747A Title not available
EP228185A Title not available
EP1310222A2 * Nov 5, 2002 May 14, 2003 Glaukos Corporation Drug-releasing trabecular implant for glaucoma treatment
FR2721499B1 Title not available
FR2757068B1 Title not available
SU1191227A1 Title not available
WO2000/64393A1 Title not available
WO2094/06503A1 Title not available
WO2007087061A2 Dec 22, 2006 Aug 2, 2007 Transcend Medical, Inc. Glaucoma treatment device
WO2008005873A2 Jun 29, 2007 Jan 10, 2008 Aquesys Inc. Methods, systems and apparatus for relieving pressure in an organ
1 Communication Relating to the Results of the Partial International Search, from PCT/US2009/033049, mailed May 15, 2009.
2 Krupin, et al., "Drainage Implants", Glaucoma, edited by Kaufman et al., Section VII.
3 Middleton, et al., "Synthetic Biodegradable Polymers as Medical Devices", Medical Plastics and Biomaterials Magagize MPB Article Index, Mar. 1998, 14 pages.
4 Prata, Jr., et al., "In Vitro and In Vivo Flow Characteristics of Glaucoma Drainage Implants," Ophthalmology, vol. 102, No. 5.
5 Sidoti, et al., "Glaucoma Drainage Implants", Current Opinion in Ophthamology.
WO2013155252A1 * Apr 11, 2013 Oct 17, 2013 Baylor College Of Medicine Ophthalmic implant
U.S. Classification 604/8, 604/266, 604/57, 604/43, 604/10, 604/30, 604/521, 604/104, 604/264, 604/239, 604/9, 604/541, 604/175, 604/265, 604/60
International Classification A61M5/00, A61F9/007, A61F2/14
Owner name: OPTONOL, LTD., ISRAEL
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YARON, IRA;DAHAN, ELIE, DR.;REEL/FRAME:020477/0865;SIGNING DATES FROM 20040624 TO 20040625
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YARON, IRA;DAHAN, ELIE, DR.;SIGNING DATES FROM 20040624 TO 20040625;REEL/FRAME:020477/0865